- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT05349110
Real-time Diagnosis of Diminutive Colorectal Polyps Using AI (COMET-OPTICAL)
Real Time Computer-aided Diagnosis (CADx) of Diminutive Colorectal Polyps Using Artificial Intelligence
Przegląd badań
Status
Interwencja / Leczenie
Szczegółowy opis
Correct endoscopic prediction of the histopathology and differentiation between benign, pre-malignant, and malignant colorectal polyps (optical diagnosis) remains difficult. Despite additional training, even experienced endoscopists continue to fail meeting international thresholds set for safe implementation of treatment strategies based on optical diagnosis.
Multiple machine learning techniques - computer-aided diagnosis (CADx) systems - have been developed for applications in medical imaging within colonoscopy and can improve endoscopic classification of colorectal polyps.
Aim of this study is to explore the feasibility of the workflow using AI4CRP (a CNN based CADx system) real-time in the endoscopy suite, and to investigate the real-time diagnostic performance of AI4CRP for the diagnosis of diminutive (<5mm) colorectal polyps. Secondary, the real-time performance of commercially available CADx systems will be investigated and compared with AI4CRP performance.
Typ studiów
Zapisy (Oczekiwany)
Kontakty i lokalizacje
Kontakt w sprawie studiów
- Nazwa: Quirine van der Zander, Drs MD
- Numer telefonu: 031433882241
- E-mail: q.vanderzander@maastrichtuniversity.nl
Kopia zapasowa kontaktu do badania
- Nazwa: Erik Schoon, Prof Dr MD
- Numer telefonu: 031433882241
- E-mail: erik.schoon@catharinaziekenhuis.nl
Lokalizacje studiów
-
-
Limburg
-
Maastricht, Limburg, Holandia, 6202AZ
- Rekrutacyjny
- Maastricht University Medical Center
-
Kontakt:
- Quirine van der Zander, Drs MD
- Numer telefonu: 031433882241
- E-mail: q.vanderzander@maastrichtuniversity.nl
-
Kontakt:
- Erik Schoon, Prof Dr MD
- Numer telefonu: 031433882241
- E-mail: erik.schoon@catharinaziekenhuis.nl
-
-
Noord-Brabant
-
Eindhoven, Noord-Brabant, Holandia, 5623 EJ
- Zakończony
- Catharina Ziekenhuis Eindhoven
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Metoda próbkowania
Badana populacja
Opis
Inclusion Criteria:
- Age >18 years;
- Patients with at least one colorectal polyps encountered during colonoscopy;
- Patients referred for a colonoscopy by the Dutch bowel cancer screening program, patients undergoing a colonoscopy for endoscopic surveillance, or patients undergoing a colonoscopy because of complaints;
- Written informed consent.
Exclusion Criteria:
- Patients with prior history of inflammatory bowel diseases (IBD) or polyposis syndromes;
- Patients with inadequate bowel preparations after adequate washing, suctioning, and cleaning manoeuvres have been performed by the endoscopist;
- Patients undergoing an emergency colonoscopy;
- Written objection in the patient file for participation in scientific research.
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
Kohorty i interwencje
Grupa / Kohorta |
Interwencja / Leczenie |
|---|---|
|
Gastroenterology patients
Patient receiving a colonoscopy because of regular care will be considered eligible for inclusion if at least one diminutive colorectal polyp is encountered during the colonoscopy. Patients receive an endoscopic procedure in the context of the Dutch national screening program, because of gastrointestinal symptoms, or because of follow-up of previously diagnosed bowel diseases. Colonoscopies will be executed using Fujifilm endoscopy systems (Fujifilm® Corporation, Tokyo, Japan), using Pentax endoscopy systems (Pentax Medical®, Hamburg, Germany), and using Olympus endoscopy systems (Olympus®, Tokyo, Japan). |
Inne nazwy:
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Technical feasibility of real-time use of AI4CRP.
Ramy czasowe: 6 months
|
The technical feasibility of real-time use of AI4CRP in the endoscopy suite regarding a proper reception of the video output from the local endoscopy processor towards AI4CRP (in high definition quality, without any delays in time).
|
6 months
|
|
User interface feasibility of real-time use of AI4CRP.
Ramy czasowe: 6 months
|
The user interface feasibility of real-time use of AI4CRP in the endoscopy suite regarding a correct alignment of the user interface of AI4CRP with the video output from the local endoscopy system (resizing image pixels and anonymization).
|
6 months
|
|
The diagnostic accuracy of AI4CRP per image modality (HDWL, BLI, LCI, i-scan).
Ramy czasowe: 1 year
|
The real-time diagnostic accuracy of AI4CRP per image modality (HDWL, BLI, LCI, i-scan).
Diagnostic accuracy defined as the percentage of correctly optically diagnosed colorectal polyps.
|
1 year
|
|
The sensitivity of AI4CRP per image modality (HDWL, BLI, LCI, i-scan).
Ramy czasowe: 1 year
|
The real-time sensitivity of AI4CRP per image modality (HDWL, BLI, LCI, i-scan).
|
1 year
|
|
The specificity of AI4CRP per image modality (HDWL, BLI, LCI, i-scan).
Ramy czasowe: 1 year
|
The real-time specificity of AI4CRP per image modality (HDWL, BLI, LCI, i-scan).
|
1 year
|
|
The negative predictive value of AI4CRP per image modality (HDWL, BLI, LCI, i-scan).
Ramy czasowe: 1 year
|
The real-time negative predictive value of AI4CRP per image modality (HDWL, BLI, LCI, i-scan).
|
1 year
|
|
The positive predictive value of AI4CRP per image modality (HDWL, BLI, LCI, i-scan).
Ramy czasowe: 1 year
|
The real-time positive predictive value of AI4CRP per image modality (HDWL, BLI, LCI, i-scan).
|
1 year
|
|
The Area Under ROC Curve (AUC) of AI4CRP per image modality (HDWL, BLI, LCI, i-scan).
Ramy czasowe: 1 year
|
The real-time Area Under ROC Curve (AUC) of AI4CRP per image modality (HDWL, BLI, LCI, i-scan).
|
1 year
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
The diagnostic accuracy of AI4CRP per polyp.
Ramy czasowe: 1 year
|
The real-time diagnostic accuracy of AI4CRP per polyp (comprising the combination of different imaging modalities).
|
1 year
|
|
The sensitivity of AI4CRP per polyp.
Ramy czasowe: 1 year
|
The real-time sensitivity of AI4CRP per polyp (comprising the combination of different imaging modalities).
|
1 year
|
|
The specificity of AI4CRP per polyp.
Ramy czasowe: 1 year
|
The real-time specificity of AI4CRP per polyp (comprising the combination of different imaging modalities).
|
1 year
|
|
The negative predictive value of AI4CRP per polyp.
Ramy czasowe: 1 year
|
The real-time negative predictive value of AI4CRP per polyp (comprising the combination of different imaging modalities).
|
1 year
|
|
The positive predictive value of AI4CRP per polyp.
Ramy czasowe: 1 year
|
The real-time positive predictive value of AI4CRP per polyp (comprising the combination of different imaging modalities).
|
1 year
|
|
The Area Under ROC Curve (AUC) of AI4CRP per polyp.
Ramy czasowe: 1 year
|
The real-time Area Under ROC Curve (AUC) of AI4CRP per polyp (comprising the combination of different imaging modalities).
|
1 year
|
|
The diagnostic accuracy of CAD EYE in BLI mode, per polyp.
Ramy czasowe: 1 year
|
The real-time diagnostic accuracy of CAD EYE in BLI mode, per polyp.
|
1 year
|
|
The sensitivity of CAD EYE in BLI mode, per polyp.
Ramy czasowe: 1 year
|
The real-time sensitivity of CAD EYE in BLI mode, per polyp.
|
1 year
|
|
The specificity of CAD EYE in BLI mode, per polyp.
Ramy czasowe: 1 year
|
The real-time specificity of CAD EYE in BLI mode, per polyp.
|
1 year
|
|
The negative predictive value of CAD EYE in BLI mode, per polyp.
Ramy czasowe: 1 year
|
The real-time negative predictive value of CAD EYE in BLI mode, per polyp.
|
1 year
|
|
The positive predictive value of CAD EYE in BLI mode, per polyp.
Ramy czasowe: 1 year
|
The real-time positive predictive value of CAD EYE in BLI mode, per polyp.
|
1 year
|
|
The Area Under ROC Curve (AUC) of CAD EYE in BLI mode, per polyp.
Ramy czasowe: 1 year
|
The real-time Area Under ROC Curve (AUC) of CAD EYE in BLI mode, per polyp.
|
1 year
|
|
The diagnostic accuracy of AI4CRP per patient.
Ramy czasowe: 1 year
|
The real-time diagnostic accuracy of AI4CRP per patient (in case of multiple polyps per patient).
|
1 year
|
|
The diagnostic accuracy of CAD EYE per patient.
Ramy czasowe: 1 year
|
The real-time diagnostic accuracy of CAD EYE per patient (in case of multiple polyps per patient).
|
1 year
|
|
The localization score of AI4CRP.
Ramy czasowe: 1 year
|
The localization score of AI4CRP regarding the number of images in which the heatmap produced by AI4CRP pointed out the area of interest (scale: correct, incorrect, or partly correct area of interest).
|
1 year
|
|
The difference in diagnostic accuracy of endoscopists per polyp before and after AI.
Ramy czasowe: 1 year
|
The difference in real-time diagnostic accuracy of endoscopists per polyp before and after AI.
|
1 year
|
|
The difference in sensitivity of endoscopists per polyp before and after AI.
Ramy czasowe: 1 year
|
The difference in real-time sensitivity of endoscopists per polyp before and after AI.
|
1 year
|
|
The difference in specificity of endoscopists per polyp before and after AI.
Ramy czasowe: 1 year
|
The difference in real-time specificity of endoscopists per polyp before and after AI.
|
1 year
|
|
The difference in negative predictive value of endoscopists per polyp before and after AI.
Ramy czasowe: 1 year
|
The difference in real-time negative predictive value of endoscopists per polyp before and after AI.
|
1 year
|
|
The difference in positive predictive value of endoscopists per polyp before and after AI.
Ramy czasowe: 1 year
|
The difference in real-time positive predictive value of endoscopists per polyp before and after AI.
|
1 year
|
|
The agreement in surveillance interval based on optical diagnosis and histopathology.
Ramy czasowe: 1 year
|
The agreement in surveillance interval based on optical diagnosis of diminutive colorectal polyps and histopathology of small and large colorectal polyps, compared to the surveillance interval based on histopathology of all colorectal polyps (diminutive, small, and large).
|
1 year
|
Współpracownicy i badacze
Śledczy
- Główny śledczy: Erik Schoon, Prof Dr MD, Maastricht Universitair Medisch Centrum
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
Zakończenie podstawowe (Oczekiwany)
Ukończenie studiów (Oczekiwany)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- METC2021-3036
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Opis planu IPD
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .